GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/SOCCER Trial: Forceps Boost Cannulation Success in Difficult ERCP- AJG Feb.26
69

SOCCER Trial: Forceps Boost Cannulation Success in Difficult ERCP- AJG Feb.26

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated February 1, 2026

Introduction

Difficult biliary cannulation remains one of the most common and consequential problems in ERCP. Failed cannulation drives repeat procedures, percutaneous or surgical rescue, higher costs, longer hospital stay—and it also increases post-ERCP pancreatitis (PEP) risk because repeated attempts and unintended pancreatic duct (PD) wire passes are key triggers.

Forceps-assisted cannulation has been used as a “trick” in challenging papillae (periampullary diverticulum, redundant folds, awkward papilla orientation), but until now it lacked randomized controlled trial evidence.

The SOCCER trial tests a simple question:

Does forceps-assisted cannulation improve success when cannulation is difficult?

Problem statement

When cannulation becomes difficult, endoscopists typically escalate to:

double-wire techniques,

precut/needle-knife access,

PD stenting strategies, etc.

These can be effective but may increase complexity and sometimes risk. A low-cost mechanical approach—using forceps to expose and stabilize the papilla—could reduce failure and potentially reduce repeated traumatic attempts. But its true efficacy needed an RCT.

What the trial did:

Randomized adults with difficult cannulation scenarios during ERCP to:

forceps-assisted cannulation, or

standard cannulation without forceps

“Difficult” included:

papilla in/on a diverticulum,

redundant tissue overlying the papilla,

challenging papilla morphology (type 2–4),

or difficult cannulation defined by attempts/time/unintended PD wire passages.

Primary outcome: successful cannulation

Secondary: difficult cannulation metrics after randomisation and PEP

Key results clinicians should remember

  1. Cannulation success improved substantially with forceps

Forceps assistance achieved near-universal cannulation success in this difficult subset, while standard cannulation had a meaningful failure rate.

  1. Crossover to forceps rescued failures

All patients who failed initial standard cannulation and then crossed over to forceps were successfully cannulated—suggesting forceps is a reliable rescue option.

  1. Forceps reduced the “trauma load” of cannulation

Even when overall difficult-cannulation rates didn’t reach statistical significance, the forceps approach resulted in fewer cannulation attempts, which is clinically important because attempts correlate with PEP risk.

  1. PEP rates were low and similar in both groups

This suggests the technique improves access without adding measurable pancreatitis risk in this trial setting.

Clinical interpretation: where this fits tomorrow

This trial supports forceps-assisted cannulation as a practical, low-cost, low-complexity tool in ERCP—especially when the papilla is hard to expose or stabilize.

Best-use scenarios

periampullary diverticulum (papilla in/on rim)

redundant folds/tissue obscuring papilla

small/protruding/creased papilla configurations (type 2–4)

early difficult cannulation where you want to avoid escalating to higher-risk access

What it does not replace

precut access when anatomy/duct orientation truly prevents standard entry

prophylaxis strategies (rectal NSAID, PD stent when indicated)

thoughtful escalation algorithms

Bottom-line takeaway for GastroAGI

In difficult ERCP cannulation, forceps assistance significantly improves cannulation success and reduces repeated attempts, without a signal for increased PEP. The SOCCER RCT moves forceps-assisted cannulation from “expert trick” to evidence-supported technique.

One-line GastroAGI takeaway

When cannulation gets difficult, forceps assistance can turn failures into successes.

Related Q&A

70

Robot-Assisted Gastric ESD Is Feasible and Safe-Endoscopy Feb.26

Introduction Endoscopic submucosal dissection (ESD) is the preferred curative treatment for early gastric cancer, but it remains technically demanding, largely because of poor traction and limited visualization during...

71

Cold EMR Is Safer Than Hot EMR for Large Colorectal Polyps-Endoscopy Feb.26

Introduction Endoscopic mucosal resection (EMR) is the standard of care for large (≥20 mm), nonpedunculated colorectal polyps. Over the last few years, cold EMR and thermal ablation–assisted EMR...

72

Even One Pancreatic Duct Cannulation Raises PEP Risk-Endoscopy Feb.25

Introduction Post-ERCP pancreatitis (PEP) remains the most frequent and feared complication of ERCP. We all recognize that repeated pancreatic duct (PD) cannulations increase risk—but in real life, many...

73

Reusable vs Single-Use Duodenoscopes: The Environmental Cost- Endoscopy Feb.26

Introduction Duodenoscope-related infection outbreaks—largely linked to reprocessing failures—drove the development of single-use duodenoscopes to eliminate cross-contamination risk. The safety argument is compelling. But ERCP already sits in a...

74

Polyps ≥10 mm Alone: Low PCCRC Risk at 5 Years- Endoscopy Feb.26

Introduction Post-polypectomy surveillance is one of the biggest drivers of colonoscopy workload worldwide. Current guidelines often label any polyp ≥10 mm as “high risk,” triggering a 3-year surveillance...

75

AI in Endoscopy: ESGE Curriculum for Safe Use- Endoscopy Feb. 26

Introduction Artificial intelligence is rapidly entering routine GI endoscopy—particularly for polyp detection, lesion characterization, and quality assurance. While early studies show improved detection and efficiency, AI also introduces...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer